Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Jazz Pharmaceuticals plc buy Morgan Stanley

Start price
€90.20
07.05.25 / 50%
Target price
€146.33
07.05.26
Performance (%)
19.68%
Price
€107.95
28.08.25
Summary
This prediction is currently active. The prediction currently has a performance of 19.68%. This prediction currently runs until 07.05.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Jazz Pharmaceuticals plc 3.898% 3.898%
iShares Core DAX® -0.930% 0.363%
iShares Nasdaq 100 1.767% 0.797%
iShares Nikkei 225® 1.666% 6.221%
iShares S&P 500 1.416% 1.109%

Comments by Morgan_Stanley for this prediction

In the thread Jazz Pharmaceuticals plc diskutieren
Prediction Buy
Perf. (%) 19.68%
Target price 146.329
Change
Ends at 07.05.26

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its price target lowered by analysts at Morgan Stanley from $183.00 to $166.00. They now have an "overweight" rating on the stock.
Ratings data for JAZZ provided by MarketBeat

Stopped prediction by Morgan_Stanley for Jazz Pharmaceuticals plc

buy
Jazz Pharmaceuticals plc

Start price
Target price
Perf. (%)
€107.95
28.08.25
-
28.08.26
0.00%
28.08.25

buy
Jazz Pharmaceuticals plc

Start price
Target price
Perf. (%)
€92.16
06.08.25
€140.03
06.08.26
17.13%
28.08.25

buy
Jazz Pharmaceuticals plc

Start price
Target price
Perf. (%)
€99.04
22.07.25
€141.14
22.07.26
9.00%
28.08.25

buy
Jazz Pharmaceuticals plc

Start price
Target price
Perf. (%)
€128.00
07.03.25
€168.73
07.03.26
-15.66%
28.08.25

buy
Jazz Pharmaceuticals plc

Start price
Target price
Perf. (%)
€120.35
12.12.24
€167.02
12.12.25
-10.30%
28.08.25